Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Volpert

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Experimental Medicine|June 9, 2004
Nuclear factor of activated T cells balances angiogenesis activation and inhibitionTetiana A Zaichuk, Emelyn H Shroff, Rebekah Emmanuel, et al.
Vascular Cell|July 11, 2015
Therapeutic manipulation of angiogenesis with miR-27bDorina Veliceasa, Dauren Biyashev, Gangjian Qin, et al.
The FEBS Journal|November 21, 2007
Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinomaDorina Veliceasa, Marina Ivanovic, Frank Thilo-Schulze Hoepfner, et al.
Journal of Theoretical Biology|March 10, 2015
Model of mucociliary clearance in cystic fibrosis lungsP Kurbatova, N Bessonov, V Volpert, et al.
Bulletin of Mathematical Biology|March 27, 2021
Patient-Specific Modelling of Blood CoagulationN Ratto, A Bouchnita, P Chelle, et al.
Genes & Development|June 8, 2001
In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effectsS Filleur, O V Volpert, A Degeorges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategyRonald Yap, Dorina Veliceasa, Urban Emmenegger, et al.
Circulation Research|July 26, 2003
Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinaseM Asif Amin, Olga V Volpert, James M Woods, et al.
The Journal of Cell Biology|July 1, 1993
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activityS S Tolsma, O V Volpert, D J Good, et al.
Science (New York, N.Y.)|July 10, 1999
Pigment epithelium-derived factor: a potent inhibitor of angiogenesisD W Dawson, O V Volpert, P Gillis, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Experimental Medicine|June 9, 2004
Nuclear factor of activated T cells balances angiogenesis activation and inhibitionTetiana A Zaichuk, Emelyn H Shroff, Rebekah Emmanuel, et al.
Vascular Cell|July 11, 2015
Therapeutic manipulation of angiogenesis with miR-27bDorina Veliceasa, Dauren Biyashev, Gangjian Qin, et al.
The FEBS Journal|November 21, 2007
Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinomaDorina Veliceasa, Marina Ivanovic, Frank Thilo-Schulze Hoepfner, et al.
Journal of Theoretical Biology|March 10, 2015
Model of mucociliary clearance in cystic fibrosis lungsP Kurbatova, N Bessonov, V Volpert, et al.
Bulletin of Mathematical Biology|March 27, 2021
Patient-Specific Modelling of Blood CoagulationN Ratto, A Bouchnita, P Chelle, et al.
Genes & Development|June 8, 2001
In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effectsS Filleur, O V Volpert, A Degeorges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategyRonald Yap, Dorina Veliceasa, Urban Emmenegger, et al.
Circulation Research|July 26, 2003
Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinaseM Asif Amin, Olga V Volpert, James M Woods, et al.
The Journal of Cell Biology|July 1, 1993
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activityS S Tolsma, O V Volpert, D J Good, et al.
Science (New York, N.Y.)|July 10, 1999
Pigment epithelium-derived factor: a potent inhibitor of angiogenesisD W Dawson, O V Volpert, P Gillis, et al.
Pageof 12